Strides Pharma to conduct trials in India for potential COVID-19 drug
Published
Indian pharmaceutical company Strides Pharma Science Ltd said on Thursday it has got regulatory approval to conduct clinical trials of antiviral drug favipiravir, considered a potential treatment for COVID-19.
Full Article